SPHK2 and hepatocellular carcinoma: We also confirmed the interaction between AHR and SPHK2 using an additional cell line (Huh7, a human hepatoma cell line, (Figure S4A, Supporting Information) and a different AHR agonist, indolo[3,2‐b] carbazole (ICZ) (Figure S4B, Supporting Information).